Inventor · disambiguated record
Victor L. Serebruany
Also filed as: SEREBRUANY VICTOR · SEREBRUANY VICTOR L · SEREBRUANY VICTOR LEONID
5 granted patents·14 pending applications·87 citations·filing 1998–2013
82Inventor score
Files withSEREBRUANY VICTOR L4BOEHRINGER INGELHEIM INT3HEARTDRUG RES L L C2BRANDT JOHN THOMAS1EISERT WOLFGANG1
Top patents by PatentIndex Score
19 records- 0184US6552014B2Methods of inhibiting platelet activation with selective serotonin reuptake inhibitorsHEARTDRUG RES L L C·Filed 2001·Granted Apr 22, 2003·21 cites·24 claims
- 0276US8232295B2Treating vascular events with statins by inhibiting PAR-1 and PAR-4SEREBRUANY VICTOR L·Filed 2010·Granted Jul 31, 2012·3 cites·6 claims
- 0372US6245782B1Methods of inhibiting platelet activation with selective serotonin reuptake inhibitorsHEARTDRUG RES L L C·Filed 1999·Granted Jun 12, 2001·37 cites·24 claims
- 0472US2009192123A1Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of Thrombin and/or by elevated expression of Thrombin receptorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 0569US7842716B2Treating vascular events with statins by inhibiting PAR-1 and PAR-4HEARTDRUG RES LLC·Filed 2004·Granted Nov 30, 2010·5 cites·1 claims
- 0656US2007105753A1Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptorsBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 0756US2010048654A1Use of valsartan or its metabolite to in hibit platelet aggregationMALININ ALEX·Filed 2009·Application pending·0 cites
- 0855US2010056519A1Composition and method for reducing platelet activation and for the treatment of thrombotic eventsSEREBRUANY VICTOR L·Filed 2009·Application pending·0 cites
- 0954US2005014770A1Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptorsBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1049US2009048173A1Use Of Dipyridamole For Treatment Of Resistance To Platelet InhibitorsEISERT WOLFGANG·Filed 2005·Application pending·0 cites
- 1149US2008171928A1Methods and systems of classifying bleeding eventsSEREBRUANY VICTOR L·Filed 2007·Application pending·0 cites
- 1248US2007213303A1Methods for reducing platelet activation and for the treatment of thrombotic eventsSCOTT ROBERT A·Filed 2006·Application pending·0 cites
- 1347US2005197372A1Use of valsartan or its metabolite to inhibit platelet aggregationFiled 2003·Application pending·0 cites
- 1447US2014162970A1Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke With Cyclopentyl-Triazolo-Pyrimidine or Derivative ThereofHEARLDRUG RES L L C·Filed 2013·Application pending·0 cites
- 1545US2003180282A1Method of treatment of thrombotic eventsFiled 2002·Application pending·0 cites
- 1641US2008214599A1Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular DiseasesBRANDT JOHN THOMAS·Filed 2006·Application pending·0 cites
- 1736US2011144049A1Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative ThereofSEREBRUANY VICTOR L·Filed 2010·Application pending·0 cites
- 1832US2011319349A1Methods for Reducing Platelet Activation and for the Treatment of Thrombotic EventsSCOTT ROBERT A D·Filed 2011·Application pending·0 cites
- 1930US6230713B1Determining a treatment plan for patients undergoing thrombotic event by monitoring P-selectinFiled 1998·Granted May 15, 2001·21 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →